83 related articles for article (PubMed ID: 643056)
1. Human pulmonary alveolar macrophages metabolise benzo(a)pyrene to proximate and ultimate mutagens.
Harris CC; Hsu IC; Stoner GD; Trump BF; Selkirk JK
Nature; 1978 Apr; 272(5654):633-4. PubMed ID: 643056
[No Abstract] [Full Text] [Related]
2. Uptake of benzo[a]pyrene--ferric oxide particulates by human pulmonary macrophages and release of benzo[a]pyrene and its metabolites.
Autrup H; Harris CC; Schafer PW; Trump BF; Stoner GD; Hsu IC
Proc Soc Exp Biol Med; 1979 Jul; 161(3):280-4. PubMed ID: 461453
[No Abstract] [Full Text] [Related]
3. Patterns of benzo[alpha]pyrene metabolism in normal human pulmonary alveolar macrophages.
Marshall MV; McLemore TL; Martin RR; Jenkins WT; Snodgrass DR; Corson MA; Arnott MS; Wray NP; Griffin AC
Cancer Lett; 1979 Dec; 8(2):103-9. PubMed ID: 555867
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of [3H]benzo[a]pyrene by cultured human bronchus and cultured human pulmonary alveolar macrophages.
Autrup H; Harris CC; Stoner GD; Selkirk JK; Schafer PW; Trump BF
Lab Invest; 1978 Mar; 38(3):217-24. PubMed ID: 633846
[No Abstract] [Full Text] [Related]
5. [Studies on the metabolism of benzo(a)pyren in alveolar-macrophages. I. Uptake of benzo(a)pyrene and induction of benzo(a)pyrene hydroxylase (author's transl)].
Dehnen W
Zentralbl Bakteriol Orig B; 1975 May; 160(3):191-211. PubMed ID: 1171562
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the metabolism of benzo(a)pyrene in alveolar-macrophages. II. Kinetics of metabolism and characterization of the metabolites (author's transl)].
Dehnen W
Zentralbl Bakteriol Orig B; 1975 Sep; 161(1):1-25. PubMed ID: 1237978
[TBL] [Abstract][Full Text] [Related]
7. Xenobiotic metabolism by alveolar type II cells isolated from rabbit lung.
Devereux TR; Fouts JR
Biochem Pharmacol; 1981 Jun; 30(11):1231-7. PubMed ID: 6268092
[No Abstract] [Full Text] [Related]
8. Induction of ouabain-resistant mutation and sister chromatid exchanges in Chinese hamster cells with chemical carcinogens mediated by human pulmonary macrophages.
Hsu IC; Harris CC; Yamaguchi M; Trump BF; Schafer PW
J Clin Invest; 1979 Nov; 64(5):1245-52. PubMed ID: 500808
[TBL] [Abstract][Full Text] [Related]
9. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests.
Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F
Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103
[No Abstract] [Full Text] [Related]
10. Comparative benzo[a]pyrene metabolite patterns in fish and rodents.
Melius P
Natl Cancer Inst Monogr; 1984 May; 65():387-90. PubMed ID: 6087145
[TBL] [Abstract][Full Text] [Related]
11. [Elimination and metabolism of benzo(a)pyrenesafter intratracheal injection].
Dehnen W; Tomingas R; Beck EG; Manojlovic N; Kirch M
Z Krebsforsch; 1970 Nov; 75(1):14-22. PubMed ID: 4252825
[No Abstract] [Full Text] [Related]
12. Cell specificity in metabolic activation of aflatoxin B1 and benzo(a)pyrene to mutagens for mammalian cells.
Langenbach R; Freed HJ; Raveh D; Huberman E
Nature; 1978 Nov; 276(5685):277-80. PubMed ID: 714158
[No Abstract] [Full Text] [Related]
13. Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positions.
Wood AW; Levin W; Lu AY; Ryan D; West SB; Yagi H; Mah HD; Jerina DM; Conney AH
Mol Pharmacol; 1977 Nov; 13(6):1116-25. PubMed ID: 339055
[No Abstract] [Full Text] [Related]
14. Localization of polycyclic hydrocarbon carcinogens in the lung following intratracheal instillation in gelatin solution.
Kennedy AR; Little JB
Cancer Res; 1975 Jun; 35(6):1563-7. PubMed ID: 1131823
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the hydroxylation of benzo(a)pyrene with the metabolism of vinyl chloride, N-nitrosomorpholine, and N-nitroso-N'-methylpiperazine to mutagens by human and rat liver microsomal fractions.
Sabadie N; Malaveille C; Camus AM; Bartsch H
Cancer Res; 1980 Jan; 40(1):119-26. PubMed ID: 7349891
[No Abstract] [Full Text] [Related]
16. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
Kari FW; Kauffman FC; Thurman RG
Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
[TBL] [Abstract][Full Text] [Related]
17. The epoxide hydratase inducer trans-stilbene oxide shifts the metabolic epoxidation of benzo(a)pyrene from the bay- to the K-region and reduces its mutagenicity.
Bücker M; Golan M; Schmassmann HU; Glatt HR; Stasiecki P; Oesch F
Mol Pharmacol; 1979 Sep; 16(2):656-66. PubMed ID: 390362
[No Abstract] [Full Text] [Related]
18. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrenes.
Buhler DR; Unlu F; Thakker DR; Slaga TJ; Newman MS; Levin W; Conney AH; Jerina DM
Cancer Res; 1982 Nov; 42(11):4779-83. PubMed ID: 6290047
[TBL] [Abstract][Full Text] [Related]
19. Selective fluorescence quenching of benzo[a]pyrene and a mutagenic diol expoxide derivative in mouse cells.
Wade CG; Baker DE; Bartholomew JC
Biochemistry; 1978 Oct; 17(20):4332-7. PubMed ID: 708717
[No Abstract] [Full Text] [Related]
20. [Behavior of carcinogenic hydrocarbons in the lung].
Brockhaus A; Tomingas R; Dehnen W; Pott F; Beck EG
Prax Pneumol; 1971 Sep; 25(9):519-26. PubMed ID: 5093491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
